Atherosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Atherosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Report Format: PDF+Excel | Report ID: SR112024A7957
Buy Now

 Market Overview:

The 7 major atherosclerosis markets reached a value of US$ 14.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.6 Billion by 2034, exhibiting a growth rate (CAGR) of 2.15% during 2024-2034.

Report Attribute
Key Statistics
Base Year 
2023
Forecast Years  2024-2034
Historical Years 
2018-2023
Market Size in 2023
US$ 14.7 Billion
Market Forecast in 2034
US$ 18.6 Billion
Market Growth Rate 2024-2034 2.15%


The atherosclerosis market has been comprehensively analyzed in IMARC's new report titled "Atherosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Atherosclerosis is a chronic disorder characterized by the buildup of plaque inside the arteries. As the disease progresses, it can narrow the artery and impede blood flow, leading to reduced oxygen and nutrient supply to the organs and tissues. This condition can affect any blood vessel within the body, but it most usually occurs in the coronary arteries. The common symptoms associated with the ailment include chest pain or discomfort, heart palpitations, dizziness, shortness of breath, cold sweats, nausea, weakness, lightheadedness, etc. Individuals suffering from this illness may further experience erectile dysfunction, heart attacks, mini-strokes, poor wound healing, etc. Atherosclerosis is typically diagnosed through a combination of medical history, physical examination, and various clinical investigations. During the physical exam, a healthcare provider checks for a weak pulse and other signs indicative of the ailment, such as abnormal sounds (bruits) over the arteries. Several diagnostic procedures and tests, including doppler ultrasound, coronary angiography, cardiac stress tests, etc., are performed to validate the diagnosis. Additionally, blood workups are also conducted to determine the lipid profile of patients, such as levels of total cholesterol and triglycerides.

Atherosclerosis Market

The rising prevalence of damage or injury to the endothelium on account of high blood pressure, smoking, increased cholesterol levels, inflammation, etc., is primarily driving the atherosclerosis market. In addition to this, the expanding geriatric population, who are prone to plaque formation due to reduced ability of lipid metabolism, is further augmenting the market growth. Moreover, the emerging popularity of effective drugs, such as antihypertensives, statins, anti-platelets, etc., which can respectively control high blood pressure, decrease cholesterol levels, and prevent blood clots, is also creating a positive outlook for the market. Apart from this, the widespread adoption of angioplasty and stenting procedures to treat patients, since they can be performed to open up blocked arteries and improve blood flow, is further bolstering the market growth. Additionally, the escalating utilization of coronary artery bypass grafting for the treatment of advanced disease conditions on account of its numerous benefits, like reduced symptoms of the illness, long-term effectiveness, and enhanced ability to perform daily activities, is expected to drive the atherosclerosis market in the coming years.

IMARC Group's new report provides an exhaustive analysis of the atherosclerosis market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for atherosclerosis and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the atherosclerosis market in any manner.

Time Period of the Study

  • Base Year: 2023
  • Historical Period: 2018-2023
  • Market Forecast: 2024-2034


Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the atherosclerosis market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the atherosclerosis market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current atherosclerosis marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     
Drugs Company Name
Crestor (Rosuvastatin) AstraZeneca
Lescol (Fluvastatin) Novartis
MEDI6570 MedImmune
RVX 000222 Resverlogix Corporation


*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

  • How has the atherosclerosis market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
  • What was the country-wise size of the atherosclerosis market across the seven major markets in 2023 and what will it look like in 2034?
  • What is the growth rate of the atherosclerosis market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the number of prevalent cases (​2018-2034​) of atherosclerosis across the seven major markets?
  • What is the number of prevalent cases (​2018-2034​) of atherosclerosis by age across the seven major markets?
  • What is the number of prevalent cases (​2018-2034​) of atherosclerosis by gender across the seven major markets?
  • How many patients are diagnosed (​2018-2034​) with atherosclerosis across the seven major markets?
  • What is the size of the atherosclerosis patient pool (2018-2023) across the seven major markets?
  • What would be the forecasted patient pool (2024-2034) across the seven major markets?
  • What are the key factors driving the epidemiological trend of atherosclerosis?
  • What will be the growth rate of patients across the seven major markets?
     

Atherosclerosis: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for atherosclerosis drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the atherosclerosis market?
  • What are the key regulatory events related to the atherosclerosis market?
  • What is the structure of clinical trial landscape by status related to the atherosclerosis market?
  • What is the structure of clinical trial landscape by phase related to the atherosclerosis market?
  • What is the structure of clinical trial landscape by route of administration related to the atherosclerosis market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Atherosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More